These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30735519)

  • 1. Desensitization and treatment with APRIL/BLyS blockade in rodent kidney transplant model.
    Bath NM; Ding X; Wilson NA; Verhoven BM; Boldt BA; Sukhwal A; Reese SR; Panzer SE; Djamali A; Redfield RR
    PLoS One; 2019; 14(2):e0211865. PubMed ID: 30735519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APRIL/BLyS Blockade Reduces Donor-specific Antibodies in Allosensitized Mice.
    Wilson NA; Bath NM; Verhoven BM; Ding X; Boldt BA; Sukhwal A; Zhong W; Panzer SE; Redfield RR
    Transplantation; 2019 Jul; 103(7):1372-1384. PubMed ID: 30830041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibody production significantly decreased with APRIL/BLyS blockade in murine chronic rejection kidney transplant model.
    Bath NM; Ding X; Verhoven BM; Wilson NA; Coons L; Sukhwal A; Zhong W; Redfield Iii RR
    PLoS One; 2019; 14(10):e0223889. PubMed ID: 31647850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APRIL/BLyS deficient rats prevent donor specific antibody (DSA) production and cell proliferation in rodent kidney transplant model.
    Bath NM; Verhoven BM; Wilson NA; Zeng W; Zhong W; Coons L; Djamali A; Redfield RR
    PLoS One; 2022; 17(10):e0275564. PubMed ID: 36227902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TACI-Ig induces immune balance of Th cells in MLN via BLyS/APRIL-receptors signaling in rats with adjuvant-induced arthritis.
    Qin Q; Chang Y; Wang D; Wu Y; Zhang LL; Wei W
    Int Immunopharmacol; 2011 Dec; 11(12):2167-75. PubMed ID: 21996540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralizing BAFF/APRIL with atacicept prevents early DSA formation and AMR development in T cell depletion induced nonhuman primate AMR model.
    Kwun J; Page E; Hong JJ; Gibby A; Yoon J; Farris AB; Villinger F; Knechtle S
    Am J Transplant; 2015 Mar; 15(3):815-22. PubMed ID: 25675879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mouse model of systemic lupus erythematosus responds better to soluble TACI than to soluble BAFFR, correlating with depletion of plasma cells.
    Haselmayer P; Vigolo M; Nys J; Schneider P; Hess H
    Eur J Immunol; 2017 Jun; 47(6):1075-1085. PubMed ID: 28383107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficient TACI expression on B lymphocytes of newborn mice leads to defective Ig secretion in response to BAFF or APRIL.
    Kanswal S; Katsenelson N; Selvapandiyan A; Bram RJ; Akkoyunlu M
    J Immunol; 2008 Jul; 181(2):976-90. PubMed ID: 18606649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-lymphocyte stimulator/a proliferation-inducing ligand heterotrimers are elevated in the sera of patients with autoimmune disease and are neutralized by atacicept and B-cell maturation antigen-immunoglobulin.
    Dillon SR; Harder B; Lewis KB; Moore MD; Liu H; Bukowski TR; Hamacher NB; Lantry MM; Maurer M; Krejsa CM; Ellsworth JL; Pederson S; Elkon KB; Wener MH; Dall'Era M; Gross JA
    Arthritis Res Ther; 2010; 12(2):R48. PubMed ID: 20302641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telitacicept as a BLyS/APRIL dual inhibitor for autoimmune disease.
    Shi F; Xue R; Zhou X; Shen P; Wang S; Yang Y
    Immunopharmacol Immunotoxicol; 2021 Dec; 43(6):666-673. PubMed ID: 34519594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effects of TACI-Ig on rat with adjuvant arthritis.
    Wang D; Chang Y; Wu Y; Zhang L; Yan S; Xie G; Qin Q; Jin J; Wang W; Fang J; Wei W
    Clin Exp Immunol; 2011 Feb; 163(2):225-34. PubMed ID: 21155990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BLyS neutralization results in selective anti-HLA alloantibody depletion without successful desensitization.
    Agarwal D; Luning Prak ET; Bharani T; Everly M; Migone TS; Cancro M; Allman D; Choe I; Kearns JD; Trofe-Clark J; Naji A; Kamoun M
    Transpl Immunol; 2021 Dec; 69():101465. PubMed ID: 34506905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretransplant Desensitization with Costimulation Blockade and Proteasome Inhibitor Reduces DSA and Delays Antibody-Mediated Rejection in Highly Sensitized Nonhuman Primate Kidney Transplant Recipients.
    Ezekian B; Schroder PM; Mulvihill MS; Barbas A; Collins B; Freischlag K; Yoon J; Yi JS; Smith F; Olaso D; Saccoccio FM; Permar S; Farris AB; Kwun J; Knechtle SJ
    J Am Soc Nephrol; 2019 Dec; 30(12):2399-2411. PubMed ID: 31658991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TACI-Ig prevents the development of airway hyperresponsiveness in a murine model of asthma.
    Bilsborough J; Chadwick E; Mudri S; Ye X; Henderson WR; Waggie K; Hebb L; Shin J; Rixon M; Gross JA; Dillon SR
    Clin Exp Allergy; 2008 Dec; 38(12):1959-68. PubMed ID: 19037968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desensitization and Prevention of Antibody-Mediated Rejection in Vascularized Composite Allotransplantation by Syngeneic Hematopoietic Stem Cell Transplantation.
    Wang HD; Fidder SAJ; Miller DT; Furtmüller GJ; Ahmadi AR; Nägele F; Lopez J; Quan A; Budihardjo J; Lough DM; Akpinarli B; Etra JW; Vasilic D; Raimondi G; Lee WPA; Montgomery RA; Sun Z; Brandacher G
    Transplantation; 2018 Apr; 102(4):593-600. PubMed ID: 29298238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effects of TACI-Ig on rats with adjuvant-induced arthritis via attenuating inflammatory responses.
    Chang Y; Wu Y; Wang D; Wei W; Qin Q; Xie G; Zhang L; Yan S; Chen J; Wang Q; Wu H; Xiao F; Sun W; Jin J; Wang W
    Rheumatology (Oxford); 2011 May; 50(5):862-70. PubMed ID: 21186171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors Predicting Risk for Antibody-mediated Rejection and Graft Loss in Highly Human Leukocyte Antigen Sensitized Patients Transplanted After Desensitization.
    Vo AA; Sinha A; Haas M; Choi J; Mirocha J; Kahwaji J; Peng A; Villicana R; Jordan SC
    Transplantation; 2015 Jul; 99(7):1423-30. PubMed ID: 25606792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD256 can be found in antibody-mediated renal allograft rejection tissues.
    Xu H; He X; Zhao W; Guo H; Shi Q; Zhu Y; Zhang X
    Clin Lab; 2012; 58(5-6):411-8. PubMed ID: 22783569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APRIL mediates peritoneal B-1 cell homeostasis.
    Sindhava VJ; Scholz JL; Stohl W; Cancro MP
    Immunol Lett; 2014 Aug; 160(2):120-7. PubMed ID: 24512739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atacicept (TACI-Ig) inhibits growth of TACI(high) primary myeloma cells in SCID-hu mice and in coculture with osteoclasts.
    Yaccoby S; Pennisi A; Li X; Dillon SR; Zhan F; Barlogie B; Shaughnessy JD
    Leukemia; 2008 Feb; 22(2):406-13. PubMed ID: 18046446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.